These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1871858)

  • 1. Rapamycin suppresses in vitro immunoglobulin production by human lymphocytes.
    Luo H; Chen H; Daloze P; Chang J; Wu J
    Transplant Proc; 1991 Aug; 23(4):2236-8. PubMed ID: 1871858
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative immunoregulatory effects of rapamycin, FK 506 and cyclosporine on mitogen-induced cytokine production and lymphoproliferation.
    Wu J; Palladino MA; Figari IS; Morris RE
    Transplant Proc; 1991 Feb; 23(1 Pt 1):238-40. PubMed ID: 1703683
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of T and B lymphocyte proliferation by rapamycin.
    Kay JE; Kromwel L; Doe SE; Denyer M
    Immunology; 1991 Apr; 72(4):544-9. PubMed ID: 1709916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin's long-term effects on humoral and cellular immune responses in the rat.
    Daloze P; Chen H; Luo H; Xu D; Shan X; Wu J
    Transplant Proc; 1993 Feb; 25(1 Pt 1):721-2. PubMed ID: 8438456
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of rapamycin on the in vitro release of soluble interleukin-2 receptor by phytohemagglutinin, phorbol myristate acetate, and ionomycin-activated peripheral blood mononuclear cells.
    Barkis I; Hadjiyannaki-Koniavitou K; Vareltzides A; Hornung N; Raskova J; Degiannis D
    Transplant Proc; 1995 Feb; 27(1):432-4. PubMed ID: 7879050
    [No Abstract]   [Full Text] [Related]  

  • 6. In vivo use of rapamycin suppresses neither IL-2 production nor IL-2 receptor expression in rat transplant model.
    Hamashima T; Yoshimura N; Ohsaka Y; Oka T; Stepkowski SM; Kahan BD
    Transplant Proc; 1993 Feb; 25(1 Pt 1):723-4. PubMed ID: 8438457
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of the proliferation of human thymocytes in vitro by rapamycin.
    Miller GA; Bansbach CC; Rabin M
    Transplantation; 1992 Oct; 54(4):763-5. PubMed ID: 1412778
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro immunosuppressive effect of deoxymethylspergualin.
    Jiang H; Takahara S; Takano Y; Machida M; Iwasaki A; Kokado Y; Kameoka H; Moutabarrik A; Ishibashi M; Sonoda T
    Transplant Proc; 1990 Aug; 22(4):1633-7. PubMed ID: 2143857
    [No Abstract]   [Full Text] [Related]  

  • 9. A nonimmunosuppressive triene-modified rapamycin analog is a potent inhibitor of peptidyl prolyl cis-trans isomerase.
    Ocain TD; Longhi D; Steffan RJ; Caccese RG; Sehgal SN
    Biochem Biophys Res Commun; 1993 May; 192(3):1340-6. PubMed ID: 7685167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resting lymphocytes are the target of cyclosporin action.
    Kimball PM; Gamaz N; Sell S
    Diabetes Res; 1988 Mar; 7(3):113-6. PubMed ID: 3262027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of action of rapamycin (Sirolimus, Rapamune).
    Molnar-Kimber KL
    Transplant Proc; 1996 Apr; 28(2):964-9. PubMed ID: 8623482
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclosporine and rapamycin block protein kinase C-mediated induction of the activation signal, activator of DNA replication, in cell-free assay.
    Kimball P; Kerman RH; Williams J; Kahan BD
    Transplant Proc; 1993 Feb; 25(1 Pt 1):518-9. PubMed ID: 8438397
    [No Abstract]   [Full Text] [Related]  

  • 13. Rapamycin and cyclosporine produce synergistic but nonidentical mechanisms of immunosuppression.
    Kimball PM; Kerman RH; Kahan BD
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1027-8. PubMed ID: 1989147
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of the in vitro immunosuppressive effects of cyclosporine A and its metabolites.
    Copeland KR; Yatscoff RW; Rush D; Jeffery JR
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1449-52. PubMed ID: 2523585
    [No Abstract]   [Full Text] [Related]  

  • 15. Lymphocyte activation mechanisms and in vitro actions of immunosuppressive drugs: a comparison.
    Dupont E; Denys C; Schandene L; Pereleux A; Romasco F; Wybran J
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1227-9. PubMed ID: 3152625
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of cyclosporine and Sirolimus on interleukin-15-driven proliferation of OKT3-preactivated human lymphocytes.
    Degiannis D; Kalteziotis V; Thalassinos A; Kapsalis A; Kroupis C; Koniavitou K
    Transplant Proc; 1998 Jun; 30(4):948-9. PubMed ID: 9636382
    [No Abstract]   [Full Text] [Related]  

  • 17. Induction of immunoglobulin and antigen-dependent antibody synthesis in human lymphocytes, using supernatants from mitogen-stimulated cultures.
    North ME; Brenner MK
    Immunology; 1983 Jan; 48(1):157-63. PubMed ID: 6600229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic interactions of cyclosporine and rapamycin to inhibit immune performances of normal human peripheral blood lymphocytes in vitro.
    Kahan BD; Gibbons S; Tejpal N; Stepkowski SM; Chou TC
    Transplantation; 1991 Jan; 51(1):232-9. PubMed ID: 1987692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malononitrilamides inhibit T- and B-cell responsiveness.
    Kurrle R; Bartlett R; Ruuth E; Lauffer L; Schorlemmer HU
    Transplant Proc; 1996 Dec; 28(6):3053-6. PubMed ID: 8962184
    [No Abstract]   [Full Text] [Related]  

  • 20. Modes of action of FK506, cyclosporin A, and rapamycin.
    Morris R
    Transplant Proc; 1994 Dec; 26(6):3272-5. PubMed ID: 7527964
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.